Page last updated: 2024-09-03

uh-ah 37 and pirenzepine

uh-ah 37 has been researched along with pirenzepine in 2 studies

*Pirenzepine: An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients. [MeSH]

*Pirenzepine: An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients. [MeSH]

Compound Research Comparison

Studies
(uh-ah 37)
Trials
(uh-ah 37)
Recent Studies (post-2010)
(uh-ah 37)
Studies
(pirenzepine)
Trials
(pirenzepine)
Recent Studies (post-2010) (pirenzepine)
7003,812587140

Protein Interaction Comparison

ProteinTaxonomyuh-ah 37 (IC50)pirenzepine (IC50)
Muscarinic acetylcholine receptor M2Homo sapiens (human)0.6891
Muscarinic acetylcholine receptor M4Homo sapiens (human)0.5856
Muscarinic acetylcholine receptor M1Rattus norvegicus (Norway rat)0.6134
Muscarinic acetylcholine receptor M3Rattus norvegicus (Norway rat)0.6222
Muscarinic acetylcholine receptor M4Rattus norvegicus (Norway rat)0.6227
Muscarinic acetylcholine receptor M5Rattus norvegicus (Norway rat)0.6227
Muscarinic acetylcholine receptor M5Homo sapiens (human)0.3406
Muscarinic acetylcholine receptor M2Rattus norvegicus (Norway rat)0.6281
Muscarinic acetylcholine receptor M1Homo sapiens (human)0.0291
Muscarinic acetylcholine receptor M1Mus musculus (house mouse)0.75
Muscarinic acetylcholine receptor M3Homo sapiens (human)0.9556
Muscarinic acetylcholine receptor M4Mus musculus (house mouse)0.75
Muscarinic acetylcholine receptor M5Mus musculus (house mouse)0.75
Muscarinic acetylcholine receptor M3Mus musculus (house mouse)0.75
Muscarinic acetylcholine receptor M2Mus musculus (house mouse)0.51

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brann, MR; Dörje, F; Lambrecht, G; Mutschler, E; Wess, J1
Ellis, J; Seidenberg, M1

Other Studies

2 other study(ies) available for uh-ah 37 and pirenzepine

ArticleYear
Selectivity profile of the novel muscarinic antagonist UH-AH 37 determined by the use of cloned receptors and isolated tissue preparations.
    British journal of pharmacology, 1991, Volume: 102, Issue:1

    Topics: Animals; Benzodiazepinones; Cells, Cultured; Cloning, Molecular; Cricetinae; Dibenzazepines; Female; Humans; In Vitro Techniques; Kinetics; Male; Membranes; Muscarinic Antagonists; Parasympatholytics; Pirenzepine; Rabbits; Rats; Rats, Inbred Strains; Receptors, Muscarinic; Species Specificity

1991
Site-directed mutagenesis implicates a threonine residue in TM6 in the subtype selectivities of UH-AH 37 and pirenzepine at muscarinic receptors.
    Pharmacology, 2000, Volume: 61, Issue:2

    Topics: Amino Acid Sequence; Animals; Benzodiazepinones; Binding, Competitive; COS Cells; Dibenzazepines; Humans; Molecular Sequence Data; Muscarinic Antagonists; Mutagenesis, Site-Directed; Parasympatholytics; Pirenzepine; Receptor, Muscarinic M2; Receptor, Muscarinic M5; Receptors, Muscarinic; Sequence Homology, Amino Acid; Threonine; Transfection

2000